Finasteride for BPH, Prostatitis, and Prostate Cancer | #MarkScholzMD #AlexScholz #PCRI @ThePCRI
Finasteride for BPH, Prostatitis, and Prostate Cancer | #MarkScholzMD #AlexScholz #PCRI  @ThePCRI
Uploaded June 2024 | Updated September 2026, 2 weeks ago
Donate to PCRI: pcri.org/donate
For more information, visit pcri.org

0:20 What is Finasteride?
1:23 What effect does Finasteride have on PSA levels?
3:06 How does Finasteride affect PSA levels for patients on active surveillance?
4:53 Is there any reason a patient should avoid Finasteride?
6:12 Is there a major alternative medicine to Finasteride?
6:53 How long to Finasteride's side effects last?
7:45 What other side effects are associated with Finasteride?
8:12 Does the dosage of Finasteride change based on his intended usage?
8:28 How does Finasteride compare to other urinary flow medication's?
9:27 What is a black box warning and how does it apply to Finasteride?
11:20 Is Finasteride considered a hormone therapy treatment?
12:40 How long does a typical course of finasteride last?
13:14 Alex's conclusions
14:25 If you need more help


Don't know your stage? Take the quiz: visit prostatecancerstaging.org

To learn more about prostate cancer, visit pcri.org

Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: pcri.org/join

Who we are:

The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better-individualized care. Feel free to explore our website at pcri.org or contact our free helpline with any questions that you have at pcri.org/helpline. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
Finasteride for BPH, Prostatitis, and Prostate Cancer | #MarkScholzMD #AlexScholz #PCRI#ProstateCancer Pain | #MarkScholzMD #PCRIAppeal Your Insurance Denial Using AI + Q&A | Nancy Wei, MD, Lauren Rhodes, & Mark Moyad, MD MPHImaging Negative Cancers | 2026 Mid-Year Update | Eugene Kwon, MD + Mark Moyad, MD Q&A #PCRI#Brachytherapy For #ProstateCancer: Clinical Trials Results  | #MarkScholzMD #PCRICastration Resistant #ProstateCancer | #MarkScholzMD #PCRIHeart, Lung, Colon, & Glaucoma Screening | #MarkScholzMD #AlexScholz #PCRI #MensHealthDo You Really Need #ProstateCancer Treatment Right Away? | #MarkScholzMD #AlexScholz #PCRIA Discussion on Nutrition & #ProstateCancer With Nutrition Expert Verne Varona & #AlexScholzPSA Bounce With #ProstateCancer Radiation #MarkScholzMD #PCRIIncontinence & Side Effects #ProstateCancer Radiation & Surgery Jeffrey Brady, MD & Mark Moyad, MDPSA Tests For #ProstateCancer | #MarkScholzMD #PCRI
Prostate Cancer Research Institute |

Finasteride for BPH, Prostatitis, and Prostate Cancer | #MarkScholzMD #AlexScholz #PCRI

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER